Cargando…
Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope
BACKGROUND: Dealing with cardiac arrhythmia is a difficult challenge. Choosing between different anti-arrhythmic drugs (AADs) while being cautious about the pro-arrhythmic characteristics of some of these drugs and their diverse interaction with other drugs is a real obstacle. MAIN BODY: Gut microbi...
Autor principal: | Nabeh, Omnia Azmy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803803/ https://www.ncbi.nlm.nih.gov/pubmed/36583819 http://dx.doi.org/10.1186/s43044-022-00325-2 |
Ejemplares similares
-
Contemporary approach to understand and manage COVID-19-related arrhythmia
por: Nabeh, Omnia Azmy, et al.
Publicado: (2021) -
Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications
por: Menshawey, Esraa, et al.
Publicado: (2021) -
“The possible implication of endothelin in the pathology of COVID-19-induced pulmonary hypertension”
por: Nabeh, Omnia Azmy, et al.
Publicado: (2021) -
Gut microbiota and cardiac arrhythmia
por: Fan, Hongxuan, et al.
Publicado: (2023) -
Non-Coding RNAs and Gut Microbiota in the Pathogenesis of Cardiac Arrhythmias: The Latest Update
por: Suga, Naoko, et al.
Publicado: (2023)